Lymphoma Management Updates for 2021

September 22, 2021

This live webinar has already taken place.

You can watch a recording of the webinar in our video library.

Take any of our Self-Paced, Online Courses and complete an assessment and an evaluation to earn free CE credit*.

 

*In most cases, Accreditation prohibit the repeated use of the same educational activity (Live Webinar or Self-Paced, Online Course but not both) as it relates to satisfying CE requirements to maintain licensure. Attendees are also required to achieve a score of 80% or better on an assessment for the Self-Paced, Online Course to receive CE credit. Please contact your individual accreditation agencies for more details.

This lecture will review some of the new drugs recently FDA approved for management of lymphoma such as CAR-T therapy for relapsed/refractory Mantle Cell Lymphoma or follicular lymphoma. For rel/ref DLBCL, polatuzumab vedotin in combination with bendamustine and rituximab as well as tafasitamab plus lenalidomide have been approved in recent years. We will review the data and outcomes.

Target Audience

These courses are intended for medical, radiation, and surgical oncologists, hematologists, advanced practice nurses, physician assistants, radiologic technologists, researchers, pharmacists, trainees, and others who are interested in care of patients with cancer in North Carolina.

Learning Objectives

  • Identify new indications for CAR-T therapy: rel/ref Mantle cell and follicular lymphoma
  • Discuss mechanism of action of polatuzumab vedotin
  • Recall long-term data for use of tafasitimab + lenalidomide in rel/ref DLBCL

 

Taking the Course

 

Click the button “Take Course” above to continue.

If you do not see the button, please ensure that you are logged in. If you are logged in and still don't see the button, please contact us at [email protected] or (919) 455–1000.

Course summary
Available credit: 
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 AMA PRA Category 1 Credit™ - Non-physician
  • 1.00 ASRT
  • 1.00 ODS
  • 1.00 NCPD/CNE
  • 1.00 Participation
Course opens: 
08/16/2021
Course expires: 
09/29/2021
Event starts: 
09/22/2021 - 11:55am EDT
Event ends: 
09/22/2021 - 1:00pm EDT
Add to calendar: 
Rating: 
0
Photo of Anne W. Beaven, MD 

Anne W. Beaven, MD

Associate Professor of Medicine
Vice Chief of Operations, Division of Hematology
UNC Lineberger Comprehensive Cancer Center
UNC School of Medicine
University of North Carolina at Chapel Hill

 

Presenter Disclosure Information

Anne W. Beaven, MD, has no relevant financial relationships with commercial interests as defined by the ACCME.

 

The Greensboro Area Health Education Center is approved as a provider of nursing continuing professional development by the North Carolina Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

Approved by the UNC Eshelman School of Pharmacy for ACPE.

Approved by the American Society of Radiologic Technologists (ASRT).

The UNC School of Medicine of The University of North Carolina at Chapel Hill is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The School of Medicine of The University of North Carolina at Chapel Hill designates this activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Available Credit

  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 AMA PRA Category 1 Credit™ - Non-physician
  • 1.00 ASRT
  • 1.00 ODS
  • 1.00 NCPD/CNE
  • 1.00 Participation
Please login or register to take this course.

Taking the Course

Click the button “Take Course” above to continue.

If you do not see the button, please ensure that you are logged in. If you are logged in and still don't see the button, please contact us at [email protected] or (919) 455–1000.